The effect of zoledronate during bone healing
- PMID: 20169393
- PMCID: PMC2837817
- DOI: 10.1007/s10195-010-0083-1
The effect of zoledronate during bone healing
Abstract
Background: Bisphosphonates have become the treatment of choice for a variety of bone diseases in which excessive osteoclastic activity is an important pathologic feature. However, inhibition of osteoclastic activity could lead to inhibition of remodeling during bone healing or repair. The objective of this study is to investigate the effect of zoledronate (the most potent bisphosphonate) in the biological process of bone healing.
Methods: Thirty immature male rabbits were divided into two groups (control and experimental) of 15 animals each. Both groups were submitted to fibular osteotomy. Only in the experimental group a single dose of zoledronate was administered. After 1, 2, and 4 weeks, animals of both groups were euthanized and the osteotomy site was histomorphometrically evaluated. The associated parameters analyzed were tissue volume (TV), fractional trabecular bone volume (BV/TV), fractional woven bone volume (WoV/TV), fractional periosteal fibrous volume (FbV/TV), and medullary fibrous volume (MaV/TV).
Results: The first week of healing was characterized by small callus area (experimental group) and less periosteal fibrosis. The second week was characterized by a large quantity of woven bone and marked decrease in periosteal fibrosis in the two groups. In the control group there was also a significant increase in trabecular bone. The fourth week was characterized by increased amount of woven bone and trabecular bone in the experimental group; there was increased medullary fibrosis in the two groups, while there continued to be significantly less periosteal fibrosis in the experimental group.
Conclusions: Zoledronate does not prevent bone healing. However, the effect of zoledronate was characterized by accentuated stimulation of primary bone production and probably inhibition of remodeling, leading to retention of trabecular bone.
Figures
Similar articles
-
The effect of zoledronate on bone remodeling during the healing process.Acta Cir Bras. 2007 Mar-Apr;22(2):115-9. doi: 10.1590/s0102-86502007000200007. Acta Cir Bras. 2007. PMID: 17375217
-
Evaluation of mandibular fracture healing in rats under zoledronate therapy: A histologic study.Injury. 2017 Dec;48(12):2683-2687. doi: 10.1016/j.injury.2017.10.026. Epub 2017 Oct 14. Injury. 2017. PMID: 29042034
-
Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing.Bone. 2015 Dec;81:702-711. doi: 10.1016/j.bone.2015.09.018. Epub 2015 Oct 3. Bone. 2015. PMID: 26434668
-
[Bone fracture and the healing mechanisms. The effects of anti-resorptive agents on fracture healing].Clin Calcium. 2009 May;19(5):673-9. Clin Calcium. 2009. PMID: 19398835 Review. Japanese.
-
Bone remodeling during fracture repair: The cellular picture.Semin Cell Dev Biol. 2008 Oct;19(5):459-66. doi: 10.1016/j.semcdb.2008.07.004. Epub 2008 Jul 25. Semin Cell Dev Biol. 2008. PMID: 18692584 Review.
Cited by
-
Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study.Rev Bras Ortop. 2015 Apr 17;50(3):274-82. doi: 10.1016/j.rboe.2015.04.004. eCollection 2015 May-Jun. Rev Bras Ortop. 2015. PMID: 26229930 Free PMC article.
-
Effects of Bisphosphonates on Osteotomy Healing in Osteogenesis Imperfecta: A Case Series.J Orthop Case Rep. 2024 Dec;14(12):283-288. doi: 10.13107/jocr.2024.v14.i12.5098. J Orthop Case Rep. 2024. PMID: 39669043 Free PMC article.
-
Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial.Med Sci Monit. 2019 Feb 23;25:1429-1438. doi: 10.12659/MSM.913236. Med Sci Monit. 2019. PMID: 30796194 Free PMC article. Clinical Trial.
-
Mobilization of endogenous stem cell populations enhances fracture healing in a murine femoral fracture model.Cytotherapy. 2013 Sep;15(9):1136-47. doi: 10.1016/j.jcyt.2013.05.004. Epub 2013 Jul 3. Cytotherapy. 2013. PMID: 23831362 Free PMC article.
-
Effects of anti-osteoporosis medications on radiological and clinical results after acute osteoporotic spinal fractures: a retrospective analysis of prospectively designed study.Osteoporos Int. 2019 Nov;30(11):2249-2256. doi: 10.1007/s00198-019-05125-0. Epub 2019 Aug 17. Osteoporos Int. 2019. PMID: 31420700
References
-
- Madsen JE, Berg-Larsen T, Kirkeby OJ, Falch JA, Nordsletten L. No adverse effects of clodronate on fracyure healing in rats. Acta Orthop Scand. 1998;69:532–536. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources